Sitagliptin - Wikipedia, the free encyclopedia
Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class ...
Dipeptidyl peptidase-4 inhibitor - Wikipedia, the free encyclopedia
Inhibitors of Dipeptidyl peptidase 4, also DPP-4 inhibitors, are a class of oral hypoglycemics that block DPP-4. The first agent of the class - sitagliptin (marketed by Merck_&_Co ...
sitagliptin - definition of sitagliptin in the Medical dictionary - by ...
sitagliptin, an oral antidiabetic. indications This drug is used alone or in combination with other antidiabetic agents to treat type 2 diabetes mellitus.
Sitagliptin: MedlinePlus Drug Information
[Posted 09/25/2009] FDA notified healthcare professionals and patients of revisions to the prescribing information for sitagliptin (Januvia) and sitagliptin/metformin (Janumet) to ...
Januvia (Sitagliptin Phosphate) Drug Information: Uses, Side Effects ...
Learn about the prescription medication Januvia (Sitagliptin Phosphate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling.
A1C reduction information available at Januvia.com
Sitagliptin As is typical with other antihyperglycemic agents used with a sulfonylurea, when sitagliptin was used in combination with metformin and a sulfonylurea, a medication ...
Sitagliptin
Sitagliptin is a prescription drug that is licensed to lower blood sugar in people with type 2 diabetes. This eMedTV page explains how the drug works to increase insulin production ...
Sitagliptin Added-on to Insulin Study - Full Text View ...
A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on insulin or insulin/metformin ...
Sitagliptin - OrganizedWisdom Health
Sitagliptin is sold under the brand name Januvia. It is an oral medication used to help lower blood sugar levels in patients with Diabetes (Type 2)|type II diabetes.
